The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase III study of comparing FOLFOX+/-bevacizumab with FOLFOX+/-bevacizumab+ high-dose intravenous vitamin C as first-line therapy in patients with advanced colorectal cancer.
 
Feng Wang
No Relationships to Disclose
 
Jian Xiao
No Relationships to Disclose
 
Yan-Qiao Zhang
No Relationships to Disclose
 
Xianglin Yuan
No Relationships to Disclose
 
Weijia Fang
No Relationships to Disclose
 
Wei Wang
No Relationships to Disclose
 
Xiaohua HU
No Relationships to Disclose
 
Zhixiang Zhuang
No Relationships to Disclose
 
Fuxiang Zhou
No Relationships to Disclose
 
Jieer Ying
No Relationships to Disclose
 
Ying Yuan
No Relationships to Disclose
 
Zeng-qing Guo
No Relationships to Disclose
 
XiangYuan Wu
No Relationships to Disclose
 
Qing-Feng Zou
No Relationships to Disclose
 
Ming-ming He
No Relationships to Disclose
 
Ying Guo
No Relationships to Disclose
 
Shuang-Zhen Chen
No Relationships to Disclose
 
Rui-hua Xu
No Relationships to Disclose